Neonatal ventilators are breathing assistance devices explicitly designed for neonatal patients—the primary method for treating failures or disorders of neonatal respiratory function in neonatal ventilators. A neonatal patient of this type is connected to a device via an endotracheal tube directly applied to the airway via a noninvasive ventilation (NIV) mask. In addition, it is used as a diagnostic tool to measure any abnormalities in the functioning of the respiratory system. There are currently two types of neonatal ventilators available: invasive and noninvasive. These neonatal ventilators are designed to provide neonates with artificial gas support via gas delivery and gas extraction, primarily in the forms of oxygen and carbon dioxide.
Preterm birth is one of the leading causes of neonatal mortality due to respiratory failure. In addition, infants with a low birth weight are more likely to experience a variety of health complications and require specialized neonatal care. Inadequate neonatal care, especially respiratory monitoring and nutritional intake, significantly contributes to the high mortality rate associated with premature births. These ventilators can improve patient compliance, accelerate healing, reduce the risk of infection, and shorten hospital stays. In addition, noninvasive neonatal ventilation is an indispensable tool for treating acute and chronic respiratory failure in-home care and intensive care settings. Shortly, noninvasive neonatal ventilators will completely replace invasive neonatal ventilators. This will allow for the highest level of patient care and administration possible. In addition, governments worldwide are collaborating with the private sector to meet the rising demand for neonatal and adult ventilators. This is being done in response to the worldwide demand for these devices.
The increase in the trend of semiconductor and bioelectronics technology has supplemented the development of circuits that consume less power and smaller batteries. The portability of neonatal ventilators is improved by having batteries with a small size and a long backup time. As a result, these devices have gradually replaced traditional ventilators over the past few years. Due to this, the market has experienced an increased demand for sophisticated and portable neonatal ventilators. As a result, technological advancements, portability, and improved designs in neonatal ventilators are anticipated to present lucrative growth opportunities for the neonatal ventilator market throughout the forecast period.
North America is the most significant revenue contributorand is estimated to reach USD 209.29 million by 2030, with a CAGR of 5.1% during the forecast period. North America holds the largest share due to the presence of cutting-edge neonatal intensive care unit (NICU) facilities, a rise in the number of new-borns with chronic respiratory failure, an increase in the number of hospitals and clinics outfitted with advanced neonatal ventilators, and the availability of portable neonatal ventilators.
The global neonatal ventilator market’s major key players are CARL Reiner GmbH, Draegerwerk AG & Co. KGaA, Fritz Stephan GmbH, General Electric Company (GE Healthcare), Getinge AB, Hamilton Medical AG, Inspiration Healthcare Group PLC (SLE Limited), Medtronic PLC (COVIDIEN LTD.), Smiths Group PLC and Vyaire Medical Inc.